Prime Medicine, Inc. (PRME)
$3.99+11.45%Close
BUYRECOVERY · day 5
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $721M
- Beta
- 2.35
- P/E (TTM)
- -3.18
- Short % float
- 54.28%
- Days to cover
- 8.4
- SI change
- -0.1%
- 1W
- +33.89%
- 1M
- +19.10%
- vs SPY 1W
- +32.73%
- vs SPY 1M
- +16.11%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on PRME?
- LOPJLB’s latest quantitative signal on Prime Medicine, Inc. (PRME) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is PRME in?
- Prime Medicine, Inc. (PRME) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Prime Medicine, Inc. (PRME) do?
- Prime Medicine, Inc. operates as a biotechnology firm, dedicated to delivering genetic therapies for various diseases by strategically employing advanced gene editing technology. Central to their platform is the "Prime Editor" system, which combines a unique Prime Editor proteinâa hybrid composed of a Cas protein and a reverse transcriptase enzymeâwith a specialized pegRNA molecule. This pe…